4//SEC Filing
Brooks Gabriel 4
Accession 0000950170-24-116246
CIK 0001707502other
Filed
Oct 21, 8:00 PM ET
Accepted
Oct 22, 4:05 PM ET
Size
8.8 KB
Accession
0000950170-24-116246
Insider Transaction Report
Form 4
Brooks Gabriel
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-10-21$6.50/sh−2,923$19,000→ 10,979 total - Exercise/Conversion
Restricted Stock Units
2024-10-18−9,750→ 29,250 total→ Common Stock (9,750 underlying) - Exercise/Conversion
Common Stock
2024-10-18+9,750→ 13,902 total
Footnotes (4)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]Includes 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2024.
- [F3]This sale was made to cover withholding taxes following the vesting of the previously granted RSUs.
- [F4]The RSUs were granted on October 18, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.
Documents
Issuer
Solid Biosciences Inc.
CIK 0001707502
Entity typeother
Related Parties
1- filerCIK 0001997809
Filing Metadata
- Form type
- 4
- Filed
- Oct 21, 8:00 PM ET
- Accepted
- Oct 22, 4:05 PM ET
- Size
- 8.8 KB